Friday - November 21, 2025

Open Angle Glaucoma Clinical Trial Landscape Expands With 20+ Emerging Therapies, Reveals DelveInsight | FDA Approvals, Medication, Therapies, Companies

Open Angle Glaucoma Pipeline Open Angle Glaucoma companies are Nicox Ophthalmics, Betaliq, Inc., Qlaris Bio, Aerpio Pharmaceuticals, Theratocular Biotek, PolyActiva Pty Ltd., Whitecap Biosciences, JeniVision, EMS and others. According to DelveInsight’s analysis, the global Open-Angle Glaucoma pipeline includes more than … Continue reading

Chronic Kidney Disease Market Poised for Strong Growth Through 2034, Reveals DelveInsight’s Latest Forecast

Chronic Kidney Disease Market Key Chronic Kidney Disease Companies are ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, KBP Biosciences, Kibow Pharma, Cincor Pharma, AstraZeneca, Allena Pharmaceuticals, DiaMedica Therapeutics Inc., Lexicon Pharmaceuticals, Sanofi, and others. … Continue reading

Sickle Cell Disease Market Analysis Report 2034: Pipeline Breakthroughs, Market Size Outlook, Key Players, and Clinical Milestones by DelveInsight

Sickle Cell Disease Market Key Sickle Cell Disease companies include Cellectis, Sana Biotechnology, Global Blood Therapeutics, Inc., CSL Behring, Pfizer, Aruvant Sciences, Graphite Bio, Novartis, Agios Pharmaceuticals, Forma Therapeutics, Vertex Pharmaceuticals, Global Blood Therapeutics, Inc., Alfasigma, Novo Nordisk, bluebird bio, … Continue reading

Dry Eye Disease Market Size was ~USD 3.76 Billion in 2023 and expected to Grow by 2034, Analysed DelveInsight

Dry Eye Disease Market Key Dry Eye Disease companies developing novel therapies include Palatin Technologies, Aldeyra Therapeutics, ReGenTree/RegeneRx, Mimetogen, Alcon/Aerie, BRIM Biotechnology, Seikagaku, Mitotech, Senju Pharmaceutical, Sylentis/PharmaMar, Stuart Therapeutics, VivaVision Biotech, HanAll/Daewoong, Redwood Pharma, OKYO Pharma, Glaukos, Oculis, and others. … Continue reading

Global NTM Infections Pipeline Poised for Growth as Breakthrough Therapies Advance Toward Late-Stage Development, states DelveInsight

NTM Infections Pipeline Key Nontuberculous Mycobacterial Infections Companies include Insmed Incorporated, Savara Inc, Paratek Pharmaceuticals Inc, LigaChem Biosciences, Spero Therapeutics, Mannkind Corporation, Pfizer, Agouron Pharmaceuticals, Pharmacia, Janssen Pharmaceutical K.K., and others. Key Nontuberculous Mycobacterial Infections Companies include Insmed Incorporated, Savara … Continue reading

Gastric Cancer Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s “Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Sickle Cell Disease Pipeline Insights Report 2025: Mechanisms of Action, Leading Companies, Clinical Advancements, and Future Market Opportunities Uncovered

DelveInsight’s “Sickle Cell Disease Pipeline Insights 2025” report provides comprehensive insights about 55+ companies and 60+ drugs in the Sickle Cell Disease Competitive landscape. It covers the Sickle Cell Disease Pipeline Therapeutics assessment by product type, stage, route of administration, … Continue reading

Breast Cancer Drug Pipeline Report 2025: Emerging MOAs, Active Developers, Clinical Advancements, and Shifting Treatment Paradigms

DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading

Acute Myeloid Leukemia Pipeline Development Outlook Report 2025: Novel Targets, R&D Growth, Pivotal Trials, and Future Market Dynamics Uncovered

DelveInsight’s “Acute Myeloid Leukemia Pipeline Insights 2025” report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Acute Myeloid Leukemia pipeline landscape. It covers the Acute Myeloid Leukemia pipeline drug profiles, including Acute Myeloid Leukemia clinical trials and … Continue reading